These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6606041)

  • 21. Mixed connective tissue disease syndrome.
    Gilliam JN; Prystowsky SD
    Arch Dermatol; 1977 May; 113(5):583-7. PubMed ID: 67824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
    Lee TK; Rothberger H
    Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
    Schrager MA; Rothfield NF
    J Clin Invest; 1976 Jan; 57(1):212-21. PubMed ID: 1245600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to fibroblasts in scleroderma.
    Brentnall TJ; Kenneally D; Barnett AJ; de Aizpurua HJ; Lolait SJ; Ashcroft R; Toh BH
    J Clin Lab Immunol; 1982 May; 8(1):9-12. PubMed ID: 7047748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of antinuclear antibodies with special reference to the immunofluorescent speckled pattern].
    Anger RD
    Z Hautkr; 1986 Nov; 61(21):1515-23. PubMed ID: 2433842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinuclear antibodies heralding the onset of systemic lupus erythematosus.
    Aho K; Koskela P; Mäkitalo R; Heliövaara M; Palosuo T
    J Rheumatol; 1992 Sep; 19(9):1377-9. PubMed ID: 1433004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
    Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
    Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
    Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
    J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Connective tissue diseases and HEp-2 antinuclear antibodies].
    Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
    Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed connective tissue disease (MCTD)--its immunological characteristics.
    Chorzelski T; Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):779-82. PubMed ID: 312087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of a flow cytometry microsphere assay to detect anti-histone antibody in dogs.
    Paul S; Wilkerson MJ; Shuman W; Harkin KR
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):315-25. PubMed ID: 16005522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear localization of immunoglobulins in renal biopsies of patients with lupus nephritis.
    McCoy RC
    Am J Pathol; 1972 Sep; 68(3):469-78. PubMed ID: 4559900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies in Thai patients with connective tissue diseases.
    Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.